Dr. Reddy's Laboratories Limited (RDY)
NYSE: RDY · Real-Time Price · USD
13.27
0.00 (-0.04%)
Apr 14, 2026, 1:19 PM EDT - Market open
Dr. Reddy's Laboratories Revenue
Dr. Reddy's Laboratories had revenue of 87.27B INR in the quarter ending December 31, 2025, with 4.41% growth. This brings the company's revenue in the last twelve months to 345.83B, up 11.09% year-over-year. In the fiscal year ending March 31, 2025, Dr. Reddy's Laboratories had annual revenue of 325.54B with 16.61% growth.
Revenue (ttm)
345.83B INR
Revenue Growth
+11.09%
P/S Ratio
2.85
Revenue / Employee
12,435,044 INR
Employees
27,811
Market Cap
10.98B USD
Revenue Chart
* This company reports financials in INR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 325.54B | 46.37B | 16.61% |
| Mar 31, 2024 | 279.16B | 33.29B | 13.54% |
| Mar 31, 2023 | 245.88B | 31.49B | 14.69% |
| Mar 31, 2022 | 214.39B | 24.67B | 13.00% |
| Mar 31, 2021 | 189.72B | 15.12B | 8.66% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Viatris | 14.30B |
| Elanco Animal Health | 4.72B |
| United Therapeutics | 3.18B |
| Amneal Pharmaceuticals | 3.02B |
| Neurocrine Biosciences | 2.86B |
| Hims & Hers Health | 2.35B |
| Lantheus Holdings | 1.54B |
| Alkermes | 1.48B |
RDY News
- 7 days ago - Dr. Reddy's Laboratories sells Svaas Wellness for Rs 2.23 crore - Business Upturn
- 7 days ago - Nifty 50 top losers today, April 7: Dr. Reddy's Laboratories, IndiGo, Adani Enterprises, Apollo Hospitals and more - Business Upturn
- 12 days ago - Top gainers among Nifty 50 stocks in midday trades today, April 2: HCL Technologies up 1.1%, Dr. Reddy's Lab up 0.3% - Business Upturn
- 19 days ago - Dr. Reddy's Laboratories issues 3,675 equity shares under ESOPs - Business Upturn
- 20 days ago - Dr Reddy's Laboratories Ltd (RDY) Trading 3.12% Higher on Mar 25 - GuruFocus
- 20 days ago - Setback for Dr Reddy’s as Delhi High Court asks company to halt Olympiq drug sales - Business Upturn
- 21 days ago - Dr. Reddy's Laboratories updates code for fair disclosure of price-sensitive information - Business Upturn
- 24 days ago - Domestic companies launch semaglutide jabs at affordable prices - The Times of India